{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Status:
Investigational
Source:
INN:deulumateperone [INN]
Source URL:
Class:
CONCEPT
Status:
Investigational
Source:
INN:enozertinib [INN]
Source URL:
Class:
CONCEPT
Status:
Investigational
Source:
NCT03326752: Phase 1 Interventional Completed Advanced Non Small Cell Lung Cancer
(2017)
Source URL:
Class:
CONCEPT
Status:
Investigational
Source:
NCT04644120: Phase 1 Interventional Completed CoronaVirus Disease-2019 (COVID-19)
(2020)
Source URL:
Class:
CONCEPT
Status:
Investigational
Source:
NCT01056107: Phase 1/Phase 2 Interventional Completed Irritable Bowel Syndrome Constipation Predominant
(2010)
Source URL:
Class:
CONCEPT
Status:
Investigational
Source:
NCT04468958: Phase 1 Interventional Completed COVID-19
(2020)
Source URL:
Class:
CONCEPT
Status:
Investigational
Source:
NCT04686175: Phase 1/Phase 2 Interventional Completed Ectonucleotide Pyrophosphatase/phosphodiesterase1 Deficiency
(2021)
Source URL:
Class:
CONCEPT
Status:
Investigational
Source:
NCT01751048: Phase 1 Interventional Completed Leishmaniasis
(2013)
Source URL:
Class:
CONCEPT
Status:
Investigational
Source:
INN:rocavorexant [INN]
Source URL:
Class:
CONCEPT
Status:
Investigational
Source:
NCT02639182: Phase 2 Interventional Completed Metastatic Renal Cell Carcinoma
(2016)
Source URL:
Class:
CONCEPT